Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$46.37 - $57.58 $51,656 - $64,144
-1,114 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$40.22 - $62.0 $44,805 - $69,068
1,114 New
1,114 $57,000
Q2 2018

Aug 14, 2018

SELL
$81.85 - $120.51 $119,337 - $175,703
-1,458 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$57.91 - $92.15 $84,432 - $134,354
1,458 New
1,458 $118,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $198M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.